Abstract
Natural killer (NK) activity against K562 target cells is not an ouabain-sensitive process. Inhibition of 40% of cytotoxicity was achieved only with an ouabain concentration much higher than that required to inhibit cell activation in other systems such as leukocyte chemotaxis and B lymphocyte plaque formation. Pretreatment of effector cells with biological agents such as phorbol-ester 12-O-tetradecanoylphorbol-13-acetate or interferon increased the cytotoxicity. This activation was not counteracted by ouabain. The effect of ouabain on NK activity was compared with a well-known ouabain-sensitive process, for example, phytohemagglutinin-induced peripheral blood lymphocyte proliferation. Ouabain completely blocked [3H]thymidine incorporation, independent of the stage of the culture when the drug was added, with exception of the last 6 h. This inhibition could be partially reversed by addition of KCl. Ouabain was equally effective when whole blood cultures were used. These results suggest that NK activity is ouabain resistant, unlike other systems of cell activation that lead or do not lead to proliferation.
Citations
Aug 1, 1994·Bioscience Reports·J FalciolaB M Anner
May 7, 2003·Hypertension·Juliana Echevarria-LimaVivian M Rumjanek
May 17, 2005·Anais Da Academia Brasileira De Ciências·Mabel B EstevesVivian M Rumjanek
Jul 21, 2011·Mediators of Inflammation·Danielle Ingrid Bezerra de VasconcelosSandra Rodrigues-Mascarenhas
Feb 25, 2009·Annals of the New York Academy of Sciences·Sandra Rodrigues-MascarenhasVivian M Rumjanek
Jun 17, 2015·Mediators of Inflammation·Jacqueline Alves LeiteSandra Rodrigues-Mascarenhas
Oct 12, 2012·Parasitology Research·P L JacobS Rodrigues-Mascarenhas
Nov 28, 2017·Frontiers in Physiology·Luiz H A Cavalcante-SilvaSandra Rodrigues-Mascarenhas
Oct 1, 1994·Bioscience Reports·B M AnnerM Moosmayer
Oct 3, 1996·European Journal of Pharmacology·V L de MoraesJ B Calixto
Feb 1, 1995·Immunopharmacology·L de La RocqueV M Rumjanek
Oct 1, 1995·General Pharmacology·C AybayH Okur
Feb 1, 1993·Immunology Letters·V L de Moraes
Jun 24, 2003·Life Sciences·Sandra Rodrigues MascarenhasVivian M Rumjanek
Jun 1, 2007·Toxicon : Official Journal of the International Society on Toxinology·André L FulyVera Lucia G Koatz
Apr 26, 2011·Immunobiology·Luciana S de PaivaVivian M Rumjanek